Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rohto Pharma Of Japan Open To Acquisition, Expansion In China

This article was originally published in PharmAsia News

Executive Summary

Japan's Rohto Pharma has decided to remain independent, although President Toshiaki Yoshino, just three months into the job, says he is not opposed to new acquisitions that would help Rohto expand. But he also wants to avoid the company being a takeover target and is looking to apply its pharmaceutical technology to help it deal with setbacks experienced under recent changes in the Pharmaceutical Affairs Law governing over-the-counter and mail-order drugs. He said Rohto also is expanding its operations in China. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts